Silo Pharma, Inc.

Nasdaq:SILO

Pharmaceutical Preparations·SARASOTA, FL

A silo is a structure for storing bulk materials.

CEO

Weisblum Eric

CFO

Ryweck Daniel E.

Summary Financials

Revenue

$72,102

+0.0% YoY

FY 2024

Adj. EBITDA

—

Net Income

-$3.7M

-5132.6% margin

FY 2024

EPS (Diluted)

-$1.20

FY 2024

Stock Price

$0.35

+2.8%

2026-03-11

52W Range

$0.22 – $1.45

P/E Ratio

-0.3x

Market Cap

$4.7M

Cash

$3.5M

FY 2024

Total Debt

$18,900

FY 2021

Net Cash

$3.5M

FY 2021

Enterprise Value

$1.2M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—

Revenue

$72,102

+0.0% YoY

FY 2024

Adj. EBITDA

—

Net Income

-$3.7M

-5132.6% margin

FY 2024

EPS (Diluted)

-$1.20

FY 2024

Stock Price

$0.35

+2.8%

2026-03-11

52W Range

$0.22 – $1.45

P/E Ratio

-0.3x

Market Cap

$4.7M

Cash

$3.5M

FY 2024

Total Debt

$18,900

FY 2021

Net Cash

$3.5M

FY 2021

Enterprise Value

$1.2M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—